Baseline characteristics and prevalence of HPV 6, 11, 16, 18 in young German women participating in phase III clinical trials of a quadrivalent HPV (6/11/16/18) vaccine.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples